Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi.
Identifieur interne : 000E51 ( PubMed/Corpus ); précédent : 000E50; suivant : 000E52Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi.
Auteurs : Terence Tafatatha ; Miriam Taegtmeyer ; Bagrey Ngwira ; Amos Phiri ; Mariot Kondowe ; Wilson Piston ; Anna Molesworth ; Ndoliwe Kayuni ; Olivier Koole ; Amelia Crampin ; John Horton ; Neil FrenchSource :
- PLoS neglected tropical diseases [ 1935-2735 ] ; 2015.
English descriptors
- KwdEn :
- Adult, Anti-Retroviral Agents (therapeutic use), Antigens, Helminth (blood), Coinfection (epidemiology), Cross-Sectional Studies, Elephantiasis, Filarial (epidemiology), HIV Infections (drug therapy), HIV Infections (epidemiology), Humans, Malawi (epidemiology), Prevalence, Rural Population (statistics & numerical data), Time Factors.
- MESH :
- chemical , blood : Antigens, Helminth.
- chemical , therapeutic use : Anti-Retroviral Agents.
- geographic , epidemiology : Malawi.
- drug therapy : HIV Infections.
- epidemiology : Coinfection, Elephantiasis, Filarial, HIV Infections.
- statistics & numerical data : Rural Population.
- Adult, Cross-Sectional Studies, Humans, Prevalence, Time Factors.
Abstract
Lymphatic filariasis (LF) and human immunodeficiency virus (HIV) are major public health problems. Individuals may be co-infected, raising the possibility of important interactions between these two pathogens with consequences for LF elimination through annual mass drug administration (MDA).
DOI: 10.1371/journal.pntd.0003825
PubMed: 26042839
Links to Exploration step
pubmed:26042839Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi.</title><author><name sortKey="Tafatatha, Terence" sort="Tafatatha, Terence" uniqKey="Tafatatha T" first="Terence" last="Tafatatha">Terence Tafatatha</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi; Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Taegtmeyer, Miriam" sort="Taegtmeyer, Miriam" uniqKey="Taegtmeyer M" first="Miriam" last="Taegtmeyer">Miriam Taegtmeyer</name><affiliation><nlm:affiliation>Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Ngwira, Bagrey" sort="Ngwira, Bagrey" uniqKey="Ngwira B" first="Bagrey" last="Ngwira">Bagrey Ngwira</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi; London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Phiri, Amos" sort="Phiri, Amos" uniqKey="Phiri A" first="Amos" last="Phiri">Amos Phiri</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi.</nlm:affiliation></affiliation></author><author><name sortKey="Kondowe, Mariot" sort="Kondowe, Mariot" uniqKey="Kondowe M" first="Mariot" last="Kondowe">Mariot Kondowe</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi.</nlm:affiliation></affiliation></author><author><name sortKey="Piston, Wilson" sort="Piston, Wilson" uniqKey="Piston W" first="Wilson" last="Piston">Wilson Piston</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi.</nlm:affiliation></affiliation></author><author><name sortKey="Molesworth, Anna" sort="Molesworth, Anna" uniqKey="Molesworth A" first="Anna" last="Molesworth">Anna Molesworth</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi; London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Kayuni, Ndoliwe" sort="Kayuni, Ndoliwe" uniqKey="Kayuni N" first="Ndoliwe" last="Kayuni">Ndoliwe Kayuni</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi.</nlm:affiliation></affiliation></author><author><name sortKey="Koole, Olivier" sort="Koole, Olivier" uniqKey="Koole O" first="Olivier" last="Koole">Olivier Koole</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi; London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Crampin, Amelia" sort="Crampin, Amelia" uniqKey="Crampin A" first="Amelia" last="Crampin">Amelia Crampin</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi; London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Horton, John" sort="Horton, John" uniqKey="Horton J" first="John" last="Horton">John Horton</name><affiliation><nlm:affiliation>Tropical Projects, Hitchin, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="French, Neil" sort="French, Neil" uniqKey="French N" first="Neil" last="French">Neil French</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26042839</idno><idno type="pmid">26042839</idno><idno type="doi">10.1371/journal.pntd.0003825</idno><idno type="wicri:Area/PubMed/Corpus">000E51</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E51</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi.</title><author><name sortKey="Tafatatha, Terence" sort="Tafatatha, Terence" uniqKey="Tafatatha T" first="Terence" last="Tafatatha">Terence Tafatatha</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi; Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Taegtmeyer, Miriam" sort="Taegtmeyer, Miriam" uniqKey="Taegtmeyer M" first="Miriam" last="Taegtmeyer">Miriam Taegtmeyer</name><affiliation><nlm:affiliation>Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Ngwira, Bagrey" sort="Ngwira, Bagrey" uniqKey="Ngwira B" first="Bagrey" last="Ngwira">Bagrey Ngwira</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi; London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Phiri, Amos" sort="Phiri, Amos" uniqKey="Phiri A" first="Amos" last="Phiri">Amos Phiri</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi.</nlm:affiliation></affiliation></author><author><name sortKey="Kondowe, Mariot" sort="Kondowe, Mariot" uniqKey="Kondowe M" first="Mariot" last="Kondowe">Mariot Kondowe</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi.</nlm:affiliation></affiliation></author><author><name sortKey="Piston, Wilson" sort="Piston, Wilson" uniqKey="Piston W" first="Wilson" last="Piston">Wilson Piston</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi.</nlm:affiliation></affiliation></author><author><name sortKey="Molesworth, Anna" sort="Molesworth, Anna" uniqKey="Molesworth A" first="Anna" last="Molesworth">Anna Molesworth</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi; London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Kayuni, Ndoliwe" sort="Kayuni, Ndoliwe" uniqKey="Kayuni N" first="Ndoliwe" last="Kayuni">Ndoliwe Kayuni</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi.</nlm:affiliation></affiliation></author><author><name sortKey="Koole, Olivier" sort="Koole, Olivier" uniqKey="Koole O" first="Olivier" last="Koole">Olivier Koole</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi; London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Crampin, Amelia" sort="Crampin, Amelia" uniqKey="Crampin A" first="Amelia" last="Crampin">Amelia Crampin</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi; London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Horton, John" sort="Horton, John" uniqKey="Horton J" first="John" last="Horton">John Horton</name><affiliation><nlm:affiliation>Tropical Projects, Hitchin, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="French, Neil" sort="French, Neil" uniqKey="French N" first="Neil" last="French">Neil French</name><affiliation><nlm:affiliation>Karonga Prevention Study, Karonga District, Malawi; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.</nlm:affiliation></affiliation></author></analytic><series><title level="j">PLoS neglected tropical diseases</title><idno type="eISSN">1935-2735</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Anti-Retroviral Agents (therapeutic use)</term><term>Antigens, Helminth (blood)</term><term>Coinfection (epidemiology)</term><term>Cross-Sectional Studies</term><term>Elephantiasis, Filarial (epidemiology)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (epidemiology)</term><term>Humans</term><term>Malawi (epidemiology)</term><term>Prevalence</term><term>Rural Population (statistics & numerical data)</term><term>Time Factors</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antigens, Helminth</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Retroviral Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Malawi</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coinfection</term><term>Elephantiasis, Filarial</term><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Rural Population</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Cross-Sectional Studies</term><term>Humans</term><term>Prevalence</term><term>Time Factors</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphatic filariasis (LF) and human immunodeficiency virus (HIV) are major public health problems. Individuals may be co-infected, raising the possibility of important interactions between these two pathogens with consequences for LF elimination through annual mass drug administration (MDA).</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26042839</PMID><DateCreated><Year>2015</Year><Month>06</Month><Day>05</Day></DateCreated><DateCompleted><Year>2016</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi.</ArticleTitle><Pagination><MedlinePgn>e0003825</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0003825</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lymphatic filariasis (LF) and human immunodeficiency virus (HIV) are major public health problems. Individuals may be co-infected, raising the possibility of important interactions between these two pathogens with consequences for LF elimination through annual mass drug administration (MDA).</AbstractText><AbstractText Label="METHODOLOGY AND PRINCIPAL FINDINGS" NlmCategory="RESULTS">We analysed circulating filarial antigenaemia (CFA) by HIV infection status among adults in two sites in northern Malawi, a region endemic for both LF and HIV. Stored blood samples and data from two geographically separate studies were used: one a recruitment phase of a clinical trial of anti-filarial agent dosing regimens, and the other a whole population annual HIV sero-survey. In study one, 1,851 consecutive adult volunteers were screened for HIV and LF infection. CFA prevalence was 25.4% (43/169) in HIV-positive and 23.6% (351/1487) in HIV-negative participants (p=0.57). Geometric mean CFA concentrations were 859 and 1660 antigen units per ml of blood (Ag/ml) respectively, geometric mean ratio (GMR) 0.85, 95%CI 0.49-1.50. In 7,863 adults in study two, CFA prevalence was 20.9% (86/411) in HIV-positive and 24.0% (1789/7452) in HIV-negative participants (p=0.15). Geometric mean CFA concentrations were 630 and 839 Ag/ml respectively (GMR 0.75, 95%CI 0.60-0.94). In the HIV-positive group, antiretroviral therapy (ART) use was associated with a lower CFA prevalence, 12.7% (18/142) vs. 25.3% (67/265), (OR 0.43, 95%CI 0.24-0.76). Prevalence of CFA decreased with duration of ART use, 15.2% 0-1 year (n=59), 13.6% >1-2 years (n=44), 10.0% >2-3 years (n=30) and 0% >3-4 years treatment (n=9), p<0.01 χ2 for linear trend.</AbstractText><AbstractText Label="CONCLUSIONS/SIGNIFICANCE" NlmCategory="CONCLUSIONS">In this large cross-sectional study of two distinct LF-exposed populations, there is no evidence that HIV infection has an impact on LF epidemiology that will interfere with LF control measures. A significant association of ART use with lower CFA prevalence merits further investigation to understand this apparent beneficial impact of ART.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tafatatha</LastName><ForeName>Terence</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Karonga Prevention Study, Karonga District, Malawi; Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taegtmeyer</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngwira</LastName><ForeName>Bagrey</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Karonga Prevention Study, Karonga District, Malawi; London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phiri</LastName><ForeName>Amos</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Karonga Prevention Study, Karonga District, Malawi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondowe</LastName><ForeName>Mariot</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Karonga Prevention Study, Karonga District, Malawi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piston</LastName><ForeName>Wilson</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Karonga Prevention Study, Karonga District, Malawi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molesworth</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Karonga Prevention Study, Karonga District, Malawi; London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kayuni</LastName><ForeName>Ndoliwe</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Karonga Prevention Study, Karonga District, Malawi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koole</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Karonga Prevention Study, Karonga District, Malawi; London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crampin</LastName><ForeName>Amelia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Karonga Prevention Study, Karonga District, Malawi; London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horton</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Tropical Projects, Hitchin, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>French</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Karonga Prevention Study, Karonga District, Malawi; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>079828/Z/06/Z</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044966">Anti-Retroviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2007 Nov 29;6:12</RefSource><PMID Version="1">18047646</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2008 Oct;79(4):558-60</RefSource><PMID Version="1">18840744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2004 Nov 15;190(10):1869-79</RefSource><PMID Version="1">15499545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2009;(3):CD006419</RefSource><PMID Version="1">19588389</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2007 Sep;77(3):507-13</RefSource><PMID Version="1">17827369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2012 Jun;41(3):676-85</RefSource><PMID Version="1">22729235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Migr. 1998;36(4):445-68</RefSource><PMID Version="1">12295093</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Braz J Infect Dis. 2001 Dec;5(6):339-44</RefSource><PMID Version="1">12010598</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2013 Jan 14;27(2):233-42</RefSource><PMID Version="1">22842993</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2006 Jun;100(6):543-50</RefSource><PMID Version="1">16324731</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2002 Jun;7(6):479-88</RefSource><PMID Version="1">12031069</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2014 Feb;19(2):224-35</RefSource><PMID Version="1">24438053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Natl Med J India. 2002 Sep-Oct;15(5):263-6</RefSource><PMID Version="1">12502137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 1996 Dec;1(6):859-64</RefSource><PMID Version="1">8980602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Parasitol. 1990 Dec;41(4):403-6</RefSource><PMID Version="1">2075384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasitol Today. 1997 Oct;13(10):401-4</RefSource><PMID Version="1">15275155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2015 Mar;9(3):e0003622</RefSource><PMID Version="1">25793933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):625-30</RefSource><PMID Version="1">21934554</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2000 Dec;182(6):1804-8</RefSource><PMID Version="1">11069260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2007 Jun;101(6):602-12</RefSource><PMID Version="1">17395223</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2002 Mar;96(2):137-44</RefSource><PMID Version="1">12080974</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Natl Med J India. 2004 Nov-Dec;17(6):304-6</RefSource><PMID Version="1">15736550</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Allergy Immunol. 2003 Dec;21(4):253-7</RefSource><PMID Version="1">15198343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2015 Jun;109(6):393-9</RefSource><PMID Version="1">25877874</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044966" MajorTopicYN="N">Anti-Retroviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008295" MajorTopicYN="N" Type="Geographic">Malawi</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC4456405</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>05</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26042839</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0003825</ArticleId><ArticleId IdType="pii">PNTD-D-14-01803</ArticleId><ArticleId IdType="pmc">PMC4456405</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E51 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000E51 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26042839
|texte= Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26042839" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |